Upon beginning Stage 2, all participants received injections of omalizumab for eight weeks. Then the participants were ...

Each was randomly assigned to a group that got an omalizumab injection or a placebo every two to four weeks for 16 to 20 weeks. All but three of the participants were 17 or younger, the ...

The approval covered two doses matching those of omalizumab -- a 75 mg/0.5 mL injection and a 150 mg/mL injection -- both to ...

Xolair comes primarily as a solution in single-dose prefilled syringes and autoinjectors for injection under your skin. Specifically, Xolair is prescribed for the following conditions: To learn ...

If you or someone you know has a condition called chronic spontaneous urticaria (CSU), you may have heard about Xolair. In 2014, Xolair became the first medicine to be approved for treating this ...

Xolair, an injection, is now available to adults and children 1 year and older to reduce risk of severe allergic reactions to foods, the FDA announced in a news release. Xolair, the brand name for ...

SAN DIEGO -- Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food allergy, largely because many patients couldn't tolerate ...

Study participants that received omalizumab-igec 150mg or reference ... a 150mg/mL single-dose prefilled syringe for subcutaneous injection. The product should be initially administered in a ...

In this phase, all 117 participants — who were 55% male, a median age of 7 and allergic to peanuts and at least two other common food allergens (milk, egg, cashew, wheat, walnut or hazelnut) — ...